Real-World Considerations for New Therapies

Key Takeaways

• New therapies must show significant clinical improvements, such as enhanced efficacy or reduced side effects, over current standards to be considered for adoption.
• Cost-effectiveness, ease of administration, and alignment with existing protocols are crucial non-clinical factors influencing treatment adoption decisions.
• The impact on healthcare resources, infrastructure, and acceptance by patients and providers are critical considerations in evaluating new therapies.